Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission

The Journal of Infectious Diseases
Olivier ManigartDiminution de la Transmission Mere-Enfant Study Group

Abstract

Perinatal zidovudine (ZDV) prophylaxis decreases rates of perinatal transmission of human immunodeficiency virus type 1 (HIV-1). Its relationship with levels of HIV-1 RNA in breast milk and postnatal transmission in breast-fed African children is unknown. At day 8 after delivery, levels of HIV-1 RNA in breast milk from 28 women who transmitted HIV-1 (Ts) postnatally and from 130 women who did not transmit HIV-1 (NTs) were lower for women receiving ZDV than for women receiving placebo. Levels of HIV-1 RNA in breast milk remained low over time in NTs but increased by 8-16-fold in Ts treated with ZDV from baseline to days 45/90 after delivery. Levels of HIV-1 RNA in breast milk at day 8 after delivery and the increase in levels of HIV-1 RNA in breast milk from day 8 to days 45/90 after delivery were independently associated with postnatal transmission. An increase in the levels of HIV-1 RNA in breast milk from day 8 to 45 after delivery was associated with maternal ZDV prophylaxis. The rebound in levels of HIV-1 RNA in breast milk after discontinuation of maternal antiretrovirals needs to be further explored--it may justify prolonging antiretroviral prophylaxis during the entire breast-feeding period.

Citations

Jul 13, 2006·AIDS Research and Human Retroviruses·William PhiriSuzanne M Filteau
Dec 17, 2009·AIDS Research and Human Retroviruses·Raabya RossenkhanM Essex
Nov 1, 2008·The Journal of Antimicrobial Chemotherapy·Andrea KunzGundel Harms
Dec 14, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael H ChungGrace C John-Stewart
Jul 21, 2012·Science Translational Medicine·Philippe Van de PerreEdouard Tuaillon
Apr 19, 2013·Science Translational Medicine·Louise KuhnGrace M Aldrovandi
Nov 22, 2014·The Journal of Infectious Diseases·Caitlin Milligan, Julie Overbaugh
May 22, 2007·La Presse médicale·Renaud Becquet, Valériane Leroy
Dec 14, 2005·Journal of Virological Methods·Pierre BecquartPhilippe Van de Perre
Mar 6, 2007·Virology·Pierre BecquartPhilippe Van de Perre
Jun 2, 2007·Reviews in Medical Virology·Dara A Lehman, Carey Farquhar
Jan 6, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jim AizireMary Glenn Fowler
Mar 6, 2015·The Pediatric Infectious Disease Journal·Amandine CournilUNKNOWN Kesho Bora Study Group
Nov 16, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nicole L DavisUNKNOWN BAN study team

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.